Zurich Cantonal Bank
PCRX icon

Zurich Cantonal Bank’s Pacira BioSciences PCRX Stock Holding History

Zurich Cantonal Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,255
Closed -$421K – 3241
2025
Q4 		$421K Buy
+16,255
New +$387K ﹤0.01% 1886

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's PCRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 8,982 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Zurich Cantonal Bank first reported a position in PCRX in Q1 2015 and has held it in 45 quarters since. The position peaked at $519K in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Zurich Cantonal Bank held 8,982 shares of Pacira BioSciences worth $228K as of Q2 2026.
  • Zurich Cantonal Bank left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2283 holding.
  • Zurich Cantonal Bank first reported a position in Pacira BioSciences in Q1 2015 and has held it in 45 quarters since.
  • Zurich Cantonal Bank's Pacira BioSciences position peaked at $519K in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.